These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1457565)

  • 1. Current status of preoperative treatment for carcinoma of the esophagus.
    Naunheim KS
    Semin Thorac Cardiovasc Surg; 1992 Oct; 4(4):270-5. PubMed ID: 1457565
    [No Abstract]   [Full Text] [Related]  

  • 2. [Multimodal therapy concepts in esophageal carcinoma].
    Porschen R; Roth SL; Röher HD; Strohmeyer G
    Dtsch Med Wochenschr; 1993 Apr; 118(17):634-40. PubMed ID: 8482241
    [No Abstract]   [Full Text] [Related]  

  • 3. [Cancers of the esophagus. Combined modality therapy by radiotherapy, chemotherapy with or without surgery].
    Calais G; Bedenne L
    Bull Cancer Radiother; 1995; 82(2):137-46. PubMed ID: 7546884
    [No Abstract]   [Full Text] [Related]  

  • 4. [Esophageal carcinoma: radiochemotherapy].
    Bidoli P; Salvini PM
    Ann Ital Chir; 1993; 64(6):641-5. PubMed ID: 8080154
    [No Abstract]   [Full Text] [Related]  

  • 5. [Perioperative multi-modality treatment strategies in esophageal cancer].
    Porschen R
    Z Gastroenterol; 1993 Nov; 31(11):680-5. PubMed ID: 8291282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A randomized clinical study of preoperative chemotherapy for esophageal carcinoma].
    Wang C; Ding T; Chang L
    Zhonghua Zhong Liu Za Zhi; 2001 May; 23(3):254-5. PubMed ID: 11783101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Posttherapy pathologic stage predicts survival in patients with esophageal carcinoma receiving preoperative chemoradiation.
    Chirieac LR; Swisher SG; Ajani JA; Komaki RR; Correa AM; Morris JS; Roth JA; Rashid A; Hamilton SR; Wu TT
    Cancer; 2005 Apr; 103(7):1347-55. PubMed ID: 15719440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Adjuvant treatment of cancers of the esophagus].
    Tiret E; Fourquier P
    Gastroenterol Clin Biol; 1994; 18(8-9):714-8. PubMed ID: 7875439
    [No Abstract]   [Full Text] [Related]  

  • 9. Who profits from neoadjuvant radiochemotherapy for locally advanced esophageal carcinoma?
    Elsaleh H; Farrell JJ; Crane CH
    J Gastroenterol Hepatol; 2009 May; 24(5):708-10. PubMed ID: 19646012
    [No Abstract]   [Full Text] [Related]  

  • 10. Management for patients with advanced T4 epidermoid carcinoma of the esophagus.
    Wang LS; Chi KH; Hu MH; Fahn HJ; Huang MH
    J Surg Oncol; 1996 May; 62(1):22-9. PubMed ID: 8618396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Failure patterns correlate with the proportion of residual carcinoma after preoperative chemoradiotherapy for carcinoma of the esophagus.
    Rohatgi PR; Swisher SG; Correa AM; Wu TT; Liao Z; Komaki R; Walsh G; Vaporciyan A; Lynch PM; Rice DC; Roth JA; Ajani JA
    Cancer; 2005 Oct; 104(7):1349-55. PubMed ID: 16130133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of preoperative adjuvant therapy of esophageal carcinoma].
    Shiozaki H; Ogawa Y; Ogawa M; Fujimoto J; Kido Y; Miyamoto T; Tane H; Kokunai I; Ueno K; Kobayashi K
    Gan To Kagaku Ryoho; 1984 Oct; 11(10):2245-51. PubMed ID: 6207778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neoadjuvant treatment of oesophageal adenocarcinoma.
    Robb WB; Naughton P; Walsh TN
    Minerva Chir; 2004 Oct; 59(5):461-70. PubMed ID: 15494673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term results of a phase II trial of neoadjuvant chemotherapy followed by esophagectomy for locally advanced esophageal neoplasm.
    Pennathur A; Luketich JD; Landreneau RJ; Ward J; Christie NA; Gibson MK; Schuchert M; Cooper K; Land SR; Belani CP
    Ann Thorac Surg; 2008 Jun; 85(6):1930-6; discussion 1936-7. PubMed ID: 18498797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cancer of the esophagus. Principles of treatment].
    Tiret E
    Ann Radiol (Paris); 1994; 37(7-8):500-3. PubMed ID: 7537948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Should adjuvant or neoadjuvant treatment be administered in esophageal cancer?].
    Bedenne L
    Ann Chir; 1997; 51(6):605-10. PubMed ID: 9406457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neoadjuvant chemoradiation versus chemotherapy for patients undergoing esophagectomy for esophageal cancer.
    Luu TD; Gaur P; Force SD; Staley CA; Mansour KA; Miller JI; Miller DL
    Ann Thorac Surg; 2008 Apr; 85(4):1217-23; discussion 1223-4. PubMed ID: 18355499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Should a complementary treatment be added to surgical treatment in cancer of the esophagus? What should be the therapeutic sequence?].
    Hay JM; Maillard JN
    Rev Prat; 1989 Nov; 39(27):2437-9. PubMed ID: 2602868
    [No Abstract]   [Full Text] [Related]  

  • 19. [Postoperative adjuvant therapies for esophageal carcinoma].
    Kuwano H; Ojima H; Kato H
    Gan To Kagaku Ryoho; 2000 Nov; 27(13):2023-7. PubMed ID: 11103232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term effects of hyperthermia combined with chemotherapy and irradiation for the treatment of patients with carcinoma of the esophagus.
    Sugimachi K; Matsuda H; Ohno S; Fukuda A; Matsuoka H; Mori M; Kuwano H
    Surg Gynecol Obstet; 1988 Oct; 167(4):319-23. PubMed ID: 3420507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.